NEX-I stands at the pinnacle of biotech advancements,
steering a transformative path in cancer immunotherapy.
With a globally recognized specialist team, we've crafted
an avant-garde platform that unveils the power of
ONCOKINE®. This novel target compels cancer cells to
resist contemporary treatments, positioning NEX-I as a
game-changer in the battle against cancer.